RUBEN MENDOZA: Open Payments
NPI 1568446748 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,405 in 71 payments from 13 companies in 2025. Trend: 2023 $862 · 2024 $1,090 · 2025 $1,405
Food & beverage: $1,405
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $190 |
| Lundbeck LLC | 8 | $189 |
| Otsuka America Pharmaceutical, Inc. | 7 | $166 |
| Teva Pharmaceuticals USA, Inc. | 14 | $142 |
| Supernus Pharmaceuticals, Inc. | 6 | $132 |
| Alkermes, Inc. | 6 | $127 |
| E.R. Squibb & Sons, L.L.C. | 5 | $118 |
| Collegium Pharmaceutical, Inc. | 6 | $118 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Tris Pharma Inc | 2 | $70 |
Products named: REXULTI, CAPLYTA, AUSTEDO XR, Qelbree, ARISTADA, COBENFY, Jornay PM, FANAPT.
Industry payments across TX — which companies pay providers there.
